Copyright Reports & Markets. All rights reserved.

Global Point-of-Care Molecular Diagnostics Market Growth (Status and Outlook) 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    Global Point-of-Care Molecular Diagnostics Market Growth (Status and Outlook) 2019-2024

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Point-of-Care Molecular Diagnostics Market Size 2014-2024
        • 2.1.2 Point-of-Care Molecular Diagnostics Market Size CAGR by Region
      • 2.2 Point-of-Care Molecular Diagnostics Segment by Type
        • 2.2.1 PCR-based
        • 2.2.2 PCR-based
        • 2.2.3 Hybridization-based
        • 2.2.4 Microarray-based
      • 2.3 Point-of-Care Molecular Diagnostics Market Size by Type
        • 2.3.1 Global Point-of-Care Molecular Diagnostics Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Point-of-Care Molecular Diagnostics Market Size Growth Rate by Type (2014-2019)
      • 2.4 Point-of-Care Molecular Diagnostics Segment by Application
        • 2.4.1 Infectious Diseases
        • 2.4.2 Oncology
        • 2.4.3 Hematology
        • 2.4.4 Prenatal Testing
        • 2.4.5 Endocrinology
        • 2.4.6 Other
      • 2.5 Point-of-Care Molecular Diagnostics Market Size by Application
        • 2.5.1 Global Point-of-Care Molecular Diagnostics Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Point-of-Care Molecular Diagnostics Market Size Growth Rate by Application (2014-2019)

      3 Global Point-of-Care Molecular Diagnostics by Players

      • 3.1 Global Point-of-Care Molecular Diagnostics Market Size Market Share by Players
        • 3.1.1 Global Point-of-Care Molecular Diagnostics Market Size by Players (2017-2019)
        • 3.1.2 Global Point-of-Care Molecular Diagnostics Market Size Market Share by Players (2017-2019)
      • 3.2 Global Point-of-Care Molecular Diagnostics Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Point-of-Care Molecular Diagnostics by Regions

      • 4.1 Point-of-Care Molecular Diagnostics Market Size by Regions
      • 4.2 Americas Point-of-Care Molecular Diagnostics Market Size Growth
      • 4.3 APAC Point-of-Care Molecular Diagnostics Market Size Growth
      • 4.4 Europe Point-of-Care Molecular Diagnostics Market Size Growth
      • 4.5 Middle East & Africa Point-of-Care Molecular Diagnostics Market Size Growth

      5 Americas

      • 5.1 Americas Point-of-Care Molecular Diagnostics Market Size by Countries
      • 5.2 Americas Point-of-Care Molecular Diagnostics Market Size by Type
      • 5.3 Americas Point-of-Care Molecular Diagnostics Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Point-of-Care Molecular Diagnostics Market Size by Countries
      • 6.2 APAC Point-of-Care Molecular Diagnostics Market Size by Type
      • 6.3 APAC Point-of-Care Molecular Diagnostics Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Point-of-Care Molecular Diagnostics by Countries
      • 7.2 Europe Point-of-Care Molecular Diagnostics Market Size by Type
      • 7.3 Europe Point-of-Care Molecular Diagnostics Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Point-of-Care Molecular Diagnostics by Countries
      • 8.2 Middle East & Africa Point-of-Care Molecular Diagnostics Market Size by Type
      • 8.3 Middle East & Africa Point-of-Care Molecular Diagnostics Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Point-of-Care Molecular Diagnostics Market Forecast

      • 10.1 Global Point-of-Care Molecular Diagnostics Market Size Forecast (2019-2024)
      • 10.2 Global Point-of-Care Molecular Diagnostics Forecast by Regions
        • 10.2.1 Global Point-of-Care Molecular Diagnostics Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Point-of-Care Molecular Diagnostics Forecast by Type
      • 10.8 Global Point-of-Care Molecular Diagnostics Forecast by Application

      11 Key Players Analysis

      • 11.1 BioMerieux
        • 11.1.1 Company Details
        • 11.1.2 Point-of-Care Molecular Diagnostics Product Offered
        • 11.1.3 BioMerieux Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 BioMerieux News
      • 11.2 F. Hoffmann-La Roche AG
        • 11.2.1 Company Details
        • 11.2.2 Point-of-Care Molecular Diagnostics Product Offered
        • 11.2.3 F. Hoffmann-La Roche AG Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 F. Hoffmann-La Roche AG News
      • 11.3 Abbott Laboratories, Bayer Healthcare
        • 11.3.1 Company Details
        • 11.3.2 Point-of-Care Molecular Diagnostics Product Offered
        • 11.3.3 Abbott Laboratories, Bayer Healthcare Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Abbott Laboratories, Bayer Healthcare News
      • 11.4 Bio-Rad Laboratories, Inc.
        • 11.4.1 Company Details
        • 11.4.2 Point-of-Care Molecular Diagnostics Product Offered
        • 11.4.3 Bio-Rad Laboratories, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Bio-Rad Laboratories, Inc. News
      • 11.5 Becton, Dickinson and Company
        • 11.5.1 Company Details
        • 11.5.2 Point-of-Care Molecular Diagnostics Product Offered
        • 11.5.3 Becton, Dickinson and Company Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Becton, Dickinson and Company News
      • 11.6 Johnson and Johnson
        • 11.6.1 Company Details
        • 11.6.2 Point-of-Care Molecular Diagnostics Product Offered
        • 11.6.3 Johnson and Johnson Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Johnson and Johnson News
      • 11.7 Cepheid, Inc.
        • 11.7.1 Company Details
        • 11.7.2 Point-of-Care Molecular Diagnostics Product Offered
        • 11.7.3 Cepheid, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Cepheid, Inc. News
      • 11.8 Danaher Corporation
        • 11.8.1 Company Details
        • 11.8.2 Point-of-Care Molecular Diagnostics Product Offered
        • 11.8.3 Danaher Corporation Point-of-Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Danaher Corporation News

      12 Research Findings and Conclusion

      According to this study, over the next five years the Point-of-Care Molecular Diagnostics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Point-of-Care Molecular Diagnostics business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares and growth opportunities of Point-of-Care Molecular Diagnostics market by product type, application, key companies and key regions.

      This study considers the Point-of-Care Molecular Diagnostics value generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
      PCR-based
      Genetic Sequencing-based
      Hybridization-based
      Microarray-based

      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
      Infectious Diseases
      Oncology
      Hematology
      Prenatal Testing
      Endocrinology
      Other

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      BioMerieux
      F. Hoffmann-La Roche AG
      Abbott Laboratories, Bayer Healthcare
      Bio-Rad Laboratories, Inc.
      Becton, Dickinson and Company
      Johnson and Johnson
      Cepheid, Inc.
      Danaher Corporation

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Point-of-Care Molecular Diagnostics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Point-of-Care Molecular Diagnostics market by identifying its various subsegments.
      Focuses on the key global Point-of-Care Molecular Diagnostics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Point-of-Care Molecular Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of Point-of-Care Molecular Diagnostics submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.
      Buy now